The UAB Molecular Genetic Pathology Fellowship Program is participating in the Molecular Genetic Pathology Unified Timeline for the 2025-2026 fellowship year. For ...
Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...
Baculoviruses are a diverse family of large, circular double‐stranded DNA viruses that infect insect larvae and play a pivotal role in natural microbial control. Advances in genomic technologies have ...
Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...
GlobalData on MSN
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...
A 50-gene subtype predictor was developed using microarray and quantitative reverse transcriptase polymerase chain reaction data from 189 prototype samples. Test sets from 761 patients (no systemic ...
BOSTON--(BUSINESS WIRE)--Invicro LLC, and Ambry Genetics, both Konica Minolta precision medicine companies and leading providers of quantitative biomarker and genomic profiling services, today ...
Fulgent Genetics will acquire assets from Bako Diagnostics and StrataDx for $55.5 million in a deal that will expand the company's offering of testing services.
Zacks Investment Research on MSN
FLGT to acquire Bako & StrataDx assets to expand pathology platform
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback